Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Exeltis USA, Inc.
FDA Inspection
•Exeltis USA, Inc.•June 6, 2017

Exeltis USA, Inc. – FDA Inspection, Jun 6, 2017

Record Details

This FDA Inspection record concerns Exeltis USA, Inc., with an inspection on June 6, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Exeltis USA, Inc.
Inspection Date
June 6, 2017
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Emmanuel J. Ramos (FDA Associated Person)
  • Guerlain Ulysse (FDA Associated Person)
View Company Profile

ID · 9ab7c541-da1d-41e2-8960-4fde32f2506c

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1014140
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

8
  1. 21 CFR 211.198(b)(3)Reason for Not Conducting Complaint Investigation
  2. 21 CFR 211.25(a)Training--operations, GMPs, written procedures
  3. 21 CFR 211.198(a)Procedures to be written and followed
  4. 21 CFR 211.166(a)Written program not followed
  5. 21 CFR 211.180(e)(2)Items to cover on annual reviews
  6. 21 CFR 111.553Written procedures - product complaint
  7. 21 CFR 111.320(a)Examination, testing; appropriate
  8. 21 CFR 111.123(a)(7)Quality control operations - finished batch, specifications

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Exeltis USA, Inc.

4
DateClassificationOfficeProject area
September 22, 2026NAICenter for Food Safety and Applied NutritionFoodborne Biological Hazards
July 2, 2025NAICenter for Food Safety and Applied NutritionFood Composition, Standards, Labeling and Econ
November 15, 2024NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
January 14, 2019NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
Other documents for Exeltis USA, Inc.
  • FDA Inspection 1333134 - 2026-09-22
  • FDA Inspection 1250586 - 2025-07-02
  • FDA Inspection 1232731 - 2024-11-15
  • FDA Inspection 1076534 - 2019-01-14

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Exeltis USA, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.